Citadel Advisors
EXAR

Citadel Advisors’s Exar Corporation EXAR Stock Holding History

Citadel Advisors’s Portfolio EXAR Stock Details EXAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,990
Closed -$208K – 8542
2017
Q1 		$208K Buy
+15,990
New +$171K ﹤0.01% 6461
2016
Q4 		– Sell
-24,696
Closed -$230K – 8270
2016
Q3 		$230K Sell
24,696
-19,398
-44% -$169K ﹤0.01% 6111
2016
Q2 		$355K Buy
44,094
+21,469
+95% +$144K ﹤0.01% 4972
2016
Q1 		$130K Buy
22,625
+9,143
+68% +$49.4K ﹤0.01% 5907
2015
Q4 		$83K Sell
13,482
-17,927
-57% -$110K ﹤0.01% 6876
2015
Q3 		$187K Buy
+31,409
New +$221K ﹤0.01% 6242
2013
Q4 		– Sell
-18,380
Closed -$247K – 7309
2013
Q3 		$247K Sell
18,380
-8,126
-31% -$103K ﹤0.01% 4560
2013
Q2 		$286K Buy
+26,506
New +$291K ﹤0.01% 4348

Citadel Advisors's EXAR Position: Q2 2017 in Review

Citadel Advisors sold out of Exar Corporation (EXAR) in Q2 2017, closing a stake of 15,990 shares — an estimated $208K sold.

Citadel Advisors first reported a position in EXAR in Q2 2013 and held it in 8 quarters. The position peaked at $355K in Q2 2016. 0 funds tracked by Wall St. Rank hold EXAR as of Q2 2017.

  • Citadel Advisors reported no remaining Exar Corporation position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 15,990 Exar Corporation shares in Q2 2017, an estimated $208K.
  • Citadel Advisors first reported a position in Exar Corporation in Q2 2013 and held it in 8 quarters.
  • Citadel Advisors's Exar Corporation position peaked at $355K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Exar Corporation as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.